Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
Our top-notch dedicated system is used to design specialised libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The procedure entails thorough molecular simulations of the catalytic and allosteric binding pockets, accompanied by ensemble virtual screening that factors in their conformational flexibility. When developing modulators, the structural modifications brought about by reaction intermediates are factored in to optimize activity and selectivity.
Our library distinguishes itself through several key aspects:
partner
Reaxense
upacc
Q8NF37
UPID:
PCAT1_HUMAN
Alternative names:
1-acylglycerol-3-phosphate O-acyltransferase; 1-acylglycerophosphocholine O-acyltransferase; 1-alkenylglycerophosphocholine O-acyltransferase; 1-alkylglycerophosphocholine O-acetyltransferase; Acetyl-CoA:lyso-platelet-activating factor acetyltransferase; Acyltransferase-like 2; Phosphonoformate immuno-associated protein 3
Alternative UPACC:
Q8NF37; Q1HAQ1; Q7Z4G6; Q8N3U7; Q8WUL8; Q9GZW6
Background:
Lysophosphatidylcholine acyltransferase 1, known by alternative names such as 1-acylglycerol-3-phosphate O-acyltransferase and Acetyl-CoA:lyso-platelet-activating factor acetyltransferase, plays a crucial role in lipid metabolism. It exhibits acyltransferase and acetyltransferase activities, catalyzing key conversions in the synthesis of phosphatidylcholine and phosphatidic acid. This enzyme prefers saturated fatty acyl-CoAs and is pivotal in respiratory physiology and platelet-activating factor biosynthesis.
Therapeutic significance:
Understanding the role of Lysophosphatidylcholine acyltransferase 1 could open doors to potential therapeutic strategies.